{
    "code": "02021032",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021032",
    "time": "2019-10-25 03:02:00",
    "許可證字號": "衛署藥輸字第021032號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/11\/18",
    "發證日期": "91\/05\/20",
    "許可證種類": "製　劑",
    "舊證字號": "02018780",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202103200",
    "中文品名": "樂拿舒注射劑 10,000 K.U.",
    "英文品名": "LEUNASE INJECTION (10,000 K.U.)",
    "適應症": "急性白血病（包括由慢性白血病轉變成急性者）惡性淋巴腫。",
    "劑型": "243凍晶注射劑",
    "包裝": "10,000K.U.小瓶 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "L-ASPARAGINASE",
    "主製造廠": {
        "申請商名稱": "1902001100  台灣協和醱酵麒麟股份有限公司",
        "申請商地址": "台北市中山區中山北路二段44號14樓",
        "主製造廠": "",
        "製造廠名稱": "FJP0983000  NIPRO PHARMA CORPORATION ODATE PLANT"
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FJP0167000  KYOWA HAKKO KIRIN CO., LTD.",
            "製造廠廠址": "1-6-1, OHTEMACHI, CHIYODA-KU, TOKYO",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1000000300",
            "成分名稱": "L-ASPARAGINASE",
            "含量描述": "",
            "含量": "10000.0000000000",
            "單位": "KU (KALLIKREIN UNIT)"
        }
    ],
    "仿單外盒": [
        {
            "title": "[Package Insert] Leunase_201802 V3-107-07-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021032&Seq=003&Type=9"
        },
        {
            "title": "[外盒圖檔] Leunase 10000_2018JUL-107-07-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021032&Seq=004&Type=8"
        }
    ]
}